336 related articles for article (PubMed ID: 32194851)
21. Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.
Kim SR; Ries V; Cheng HC; Kareva T; Oo TF; Yu WH; Duff K; Kholodilov N; Burke RE
Neurobiol Dis; 2011 Nov; 44(2):215-22. PubMed ID: 21782946
[TBL] [Abstract][Full Text] [Related]
22. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
23. Nicotine-Mediated Recruitment of GABAergic Neurons to a Dopaminergic Phenotype Attenuates Motor Deficits in an Alpha-Synuclein Parkinson's Model.
Lai JI; Porcu A; Romoli B; Keisler M; Manfredsson FP; Powell SB; Dulcis D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835612
[TBL] [Abstract][Full Text] [Related]
24. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
25. Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects.
Khodr CE; Becerra A; Han Y; Bohn MC
Brain Res; 2014 Mar; 1550():47-60. PubMed ID: 24463035
[TBL] [Abstract][Full Text] [Related]
26. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression.
Wang Y; Wang Q; Yu R; Zhang Q; Zhang Z; Li H; Ren C; Yang R; Niu H
Aging (Albany NY); 2020 Jul; 12(14):14232-14243. PubMed ID: 32706757
[TBL] [Abstract][Full Text] [Related]
27. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
28. Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.
Selvaraj S; Sun Y; Watt JA; Wang S; Lei S; Birnbaumer L; Singh BB
J Clin Invest; 2012 Apr; 122(4):1354-67. PubMed ID: 22446186
[TBL] [Abstract][Full Text] [Related]
29. The new line of genetically modified mice with constitutive knockout of the gene alpha synuclein to study pathogenetic aspects of differential loss of dopaminergic neurons .
Tarasova TV; Ustyugov AA; Ninkina NN; Skvortsova VI
Patol Fiziol Eksp Ter; 2016; 60(3):4-9. PubMed ID: 29243900
[TBL] [Abstract][Full Text] [Related]
30. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
[TBL] [Abstract][Full Text] [Related]
31. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
[TBL] [Abstract][Full Text] [Related]
32. Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.
Subramaniam M; Kern B; Vogel S; Klose V; Schneider G; Roeper J
Eur J Neurosci; 2014 Sep; 40(6):2898-909. PubMed ID: 25059097
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
[TBL] [Abstract][Full Text] [Related]
34. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
35. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression.
Chung CY; Koprich JB; Hallett PJ; Isacson O
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22474-9. PubMed ID: 20007772
[TBL] [Abstract][Full Text] [Related]
36. Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.
Keane PC; Hanson PS; Patterson L; Blain PG; Hepplewhite P; Khundakar AA; Judge SJ; Kahle PJ; LeBeau FEN; Morris CM
Neurosci Lett; 2019 Oct; 711():134437. PubMed ID: 31422098
[TBL] [Abstract][Full Text] [Related]
37. Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy.
Cheng XY; Li SY; Mao CJ; Wang MX; Chen J; Wang F; Wang GH; Deng WB; Li XK; Liu CF
Neuroscience; 2018 Feb; 371():288-295. PubMed ID: 29196028
[TBL] [Abstract][Full Text] [Related]
38. Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.
von Bohlen und Halbach O; Minichiello L; Unsicker K
FASEB J; 2005 Oct; 19(12):1740-2. PubMed ID: 16037097
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP+ via regulation of gene expression.
Liu Y; Lu Z
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):841-848. PubMed ID: 29575151
[TBL] [Abstract][Full Text] [Related]
40. Dopamine and α-synuclein dysfunction in Smad3 null mice.
Tapia-González S; Giráldez-Pérez RM; Cuartero MI; Casarejos MJ; Mena MÁ; Wang XF; Sánchez-Capelo A
Mol Neurodegener; 2011 Oct; 6():72. PubMed ID: 21995845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]